Alkermes (ALKS) Tax Provisions (2010 - 2026)
Alkermes (ALKS) posted quarterly Tax Provisions of -$2.4 million for Q2 2026, down 113.53% year-over-year from $17.7 million in Q2 2025, and down 152.17% quarter-over-quarter from $4.6 million in Q1 2026.
Alkermes (ALKS) Tax Provisions (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Tax Provisions for 17 consecutive years, with -$2.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions fell 113.53% year-over-year to -$2.4 million; the TTM figure through Jun 2026 stood at $31.2 million (down 49.95% YoY), while the FY2025 annual figure was $49.8 million, down 30.48% from the prior year.
- Tax Provisions fell to -$2.4 million in Q2 2026 per ALKS's latest filing, from $4.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at $26.8 million in Q4 2022 and bottomed at -$102.2 million in Q4 2023.
- Historically, Tax Provisions has averaged $2.1 million across 5 years, with a median of $3.8 million in 2025.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 1373.42% — and 2023, when it plunged 481.88%.
- Alkermes' Tax Provisions stood at $26.8 million in 2022, then slumped by 481.88% to -$102.2 million in 2023, then jumped by 123.58% to $24.1 million in 2024, then sank by 54.44% to $11.0 million in 2025, then tumbled by 121.85% to -$2.4 million in 2026.
- Business Quant data shows ALKS's Tax Provisions at -$2.4 million in Q2 2026, $4.6 million in Q1 2026, and $11.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.40 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 17.74 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 24.11 Mn |
| Sep 30, 2024 | 17.44 Mn |
| Jun 30, 2024 | 22.10 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | -102.24 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 717,000.00 |
| Dec 31, 2022 | 26.77 Mn |
| Sep 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | -3.11 Mn |
| Mar 31, 2022 | -9.10 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 2.45 Mn |